TAG:
biopsy
Beckman Coulter, Olympus, LabCorp, Anthem, WellPoint, Medtox, University of Toronto
By Robert Michel | From the Volume XVII No. 3 – February 15, 2010 Issue
BECKMAN COULTER REPORTS EARNINGS THAT INCLUDE OLYMPUS THERE WAS A BIG JUMP in fourth quarter revenue at Beckman Coulter Inc., of Brea, California, which increased by 22% over the previous year, to $989.6 million. This number included $120.2 million in reven…
November 02, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 15 – November 02, 2009 Issue
Digital microfluidics and lab-on-a-chip technologies are being combined to create a new way to measure breast estrogen levels in women. An interdisciplinary group at the University of Toronto developed a lab-on-a-chip technique to analyze blood and breast tissue to identify women at …
Scripps’ Tumor Board Finds Value in Digital Imaging of Slides
By Robert Michel | From the Volume XVI No. 14 – October 12, 2009 Issue
CEO Summary: When the Pathology Department at Scripps Memorial Hospital in La Jolla, California, was considering the purchase of a digital imaging system, it gained unlikely allies. Non-pathologist physicians participating in the department’s tumor boards advocated for the purchase afte…
Using Lean at Henry Ford Transforms Pathology TAT
By Robert Michel | From the Volume XVI No. 11 – August 10, 2009 Issue
CEO SUMMARY: Long-standing work flow traditions in anatomic pathology provide fertile ground for improvement with Lean and similar process improvement methods. That was the case at Henry Ford Health System, where empowered teams in the pathology laboratory employed the principles…
Why Wall Street Likes Histology Lab Business
By Robert Michel | From the Volume XVI No. 6 – April 27, 2009 Issue
CEO SUMMARY: Over the past two decades, investor-owned anatomic pathology companies captured significant market share from community hospital-based pathology groups while delivering profits to their owners. Despite the recent downturn in the economy, Wall Street believes histolog…
Boston’s Beth Israel Scores Improvement Gains with Lean
By Robert Michel | From the Volume XVI No. 4 – March 16, 2009 Issue
CEO Summary: Lean methods are helping laboratories resolve aggravating problems that have been unresolvable for as long as 10 years. At Beth Israel Deaconess Medical Center in Boston, improvement teams involving the laboratory and ED staff addressed high rates of hemolyzed specim…
Molecular Advances Soon To Reshape Anatomic Path
By Robert Michel | From the Volume XVI No. 3 – February 23, 2009 Issue
CEO SUMMARY: Early this month, the second annual Molecular Summit assembled molecular first movers and early adopters to discuss their efforts to integrate molecular imaging and molecular diagnostics in patient care. One clear message emerged from two days of presentations and di…
Canadian Pathologists Start PT Testing for ER/PR
By Robert Michel | From the Volume XV No. 11 – August 18, 2008 Issue
CEO SUMMARY: Experts point out that widely publicized episodes of lab testing deficiencies in several provinces are signs that chronic underfunding of lab testing services is a key factor in these failures. To restore public confidence in breast cancer testing, the Canadian Association of…
GE, UPMC Create Company for Digital Path Imaging
By Robert Michel | From the Volume XV No. 8 – June 16, 2008 Issue
CEO SUMMARY: It’s a new joint venture with the potential to transform surgical pathology. General Electric Healthcare has extensive experience at supporting physicians’ work flow with digitized imaging systems, plus ample experience with molecular bio-markers. The University of Pittsb…
Powerful Trends Reshaping Anatomic Path Profession
By Robert Michel | From the Volume XV No. 2 – February 11, 2008 Issue
CEO SUMMARY: THE DARK REPORT presents its newest biannual review of macro trends reshaping the anatomic pathology profession. These macro trends reveal a profession undergoing change and transformation on multiple fronts. New competitors are crowding into the market, payers and accreditin…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized